In the news

Ken Stein, MD, senior vice president and global chief medical officer, highlights how AI is being applied today to deliver more proactive, personalized and precise medical

Jodi Eddy, chief information and digital officer, explains the importance of ensuring IT teams at rapidly growing organizations are at the table when key initiatives are being discussed.

Boston Scientific has approximately doubled its Minnesota workforce in the last 15 years. It has become the largest employer in both Maple Grove and Arden Hills. And it’s not done expanding.

Jodi Eddy, chief information and digital officer, unpacks three aspects of corporate culture that are separating leaders from the pack in the global pursuit of generative AI adoption.

Dr. Brad Sutton, chief medical officer, Atrial Fibrillation Solutions, discusses two of the latest FARAPULSE™ Pulsed Field Ablation System innovations and how the acquisition of Cortex, Inc. will fit into the Boston Scientific Electrophysiology portfolio.

In an interview with CNBC’s Jim Cramer, CEO Mike Mahoney shares how breakthrough products, an active venture portfolio and strategic acquisitions continue to drive high business performance.

Ken Stein, MD, senior vice president and global chief medical officer, discuss health inequities and Boston Scientific's work to improve access to care for underserved populations.

Boston Scientific presented a study at the 23rd American Society of Regional Anesthesia and Pain Medicine Meeting that demonstrates Fast-Acting Sub-Perception Therapy (FAST), with the WaveWriter spinal cord stimulation systems, as a breakthrough solution that significantly reduces chronic pain and improves patient outcomes with high satisfaction for up to 12 months, and no increase in opioid use during the primary endpoint interval.

Jodi Euerle Eddy, chief information and digital officer, shares the importance of interdepartmental collaboration in creating a culture of innovation that supports the investment, deployment and successful adoption of new technology.

As the number of people diagnosed with atrial fibrillation (AF) rises around the world, Ken Stein, MD, senior vice president and global chief medical officer and Nick Spadea-Annello, global president, Electrophysiology, along with industry experts, offer the Star Tribune perspective on the paradigm shift to pulsed field ablation for the treatment of AF, the explosive growth of the FARAPULSE™ Pulsed Field Ablation System, the competitive innovation race and the future of cardiac care.